J Korean Med Sci.  2000 Feb;15(1):37-43. 10.3346/jkms.2000.15.1.37.

Outcome of adults with repaired tetralogy of Fallot

Affiliations
  • 1Department of Pediatrics, Ewha Womans University, College of Medicine, Seoul, Korea. sohn@mm.ewha.ac.kr

Abstract

Outcome of adult patients with repaired tetralogy of Fallot (TOF) was studied with emphasis on postrepair problems. A retrospective review of clinical, echocardiographic, catheterization, and surgical data was performed for 48 patients who underwent corrective repair of TOF after 15 years of age. All patients survived total repair and have been followed up from 3 months to 11 years (median 4.6 years). Postoperatively, 81.3% of patients were in functional class I and 85.4% had normal right ventricular function. One patient (2.1%) died during follow-up. There were 6 reoperations (12.5%) in 5 patients. The indications for reoperation included residual ventricular septal defect (VSD) (n=1), right ventricular outflow obstruction with VSD (n=4), and pulmonary regurgitation (n=1). The 10-year actuarial survival rate was 97.1%, and the 10-year freedom from reoperation was 81.3%. Aortic regurgitation was seen preoperatively in 6 patients (12.5%) and there were 2 newly developed aortic regurgitations after operation, one of which was caused by infective endocarditis. Corrective repair of TOF can be recommended in this patient group since the survival rate, postrepair functional status and hemodynamics are acceptable. Continued close follow-up, however, is essential for early identification and correction of post-repair problems.

Keyword

Tetralogy of Fallot; Reoperation; Cardiovascular Abnomalities; Heart Defects; Congenital

MeSH Terms

Adolescence
Adult
Aortic Valve Insufficiency/etiology
Electrocardiography
Female
Follow-Up Studies
Human
Male
Postoperative Complications
Reoperation
Retrospective Studies
Tetralogy of Fallot/surgery*
Treatment Outcome
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr